May 3—Mosaic Life Care announced Friday a new foundation designed to help patients with spinal muscular atrophy. Mosaic CEO Mike Poore made a statement Friday morning confirming Mosaic's commencement ...
The tiny zebrafish is helping researchers rapidly determine whether a newborn's genetic mutation is likely to cause spinal ...
News-Medical.Net on MSN
Zebrafish can play a decisive role in clinical interpretation of spinal muscular atrophy
The tiny zebrafish is helping researchers rapidly determine whether a newborn's genetic mutation is likely to cause spinal ...
A gene therapy candidate extended survival in a mouse model of SMARD1, supporting its testing in a clinical trial for this ...
SCHAUMBURG, Ill., Nov. 26, 2025 /PRNewswire/ -- Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of ...
Spinal muscular atrophy (SMA) is a progressive genetic disease that causes devastating muscle atrophy and disease-related complications. SMA is the leading genetic cause of death in infants and ...
Please provide your email address to receive an email when new articles are posted on . The European Medicines Agency has granted orphan drug designation to a small molecule intended to treat spinal ...
FRESNO, Calif. -- Richard and Kaylee Lazaro had just welcomed twins Rykker and Bekkem, but Rykker was rushed to the NICU and later diagnosed with Spinal Muscular Atrophy (SMA). He was able to receive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results